home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  December 18, 2017
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 591 active entries

Institute for Biopharmaceutical Research (IBR)-Inc.

Lauchefeld 31
9548 Matzingen, Switzerland

Phone: +41 52 366 35 20
Fax: +41 52 366 35 21

Stock symbol: IBR-Inc.
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


The Institute for Biopharmaceutical Research (IBR)-Inc. was founded in January 1998 as a spin-off company of the University of Zurich. The IBR runs GLP compliant test facilities engaged in contract research focusing on preclinical development of biopharmaceutical products.
Fields of scientific expertise: mechanisms of inflammatory diseases, cellular immunology

Main techniques and methods in immunology, cell biology, molecular biology, biochemistry, cell cultures, cell banking, cellular physiology
Special techniques:
Cytofluorometry with FACS Calibur, protein analytics, quantitative PCR

Selected Categories:
Product Company   Service Company
- Research
- Software
- Research
- Services
- Analytical

Last update of this entry: July 14, 2015

Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.